Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans
about
Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMPStability-mediated epistasis constrains the evolution of an influenza proteinHeterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesThe Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of InfluenzaUniversal immunity to influenza must outwit immune evasionBeyond model antigens: high-dimensional methods for the analysis of antigen-specific T cellsCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesClassification of the Universe of Immune Epitope Literature: Representation and Knowledge GapsCross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A virusesCrystal Structure of Swine Major Histocompatibility Complex Class I SLA-1*0401 and Identification of 2009 Pandemic Swine-Origin Influenza A H1N1 Virus Cytotoxic T Lymphocyte Epitope PeptidesCross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive IndividualsPreemptive priming readily overcomes structure-based mechanisms of virus escapeA population response analysis approach to assign class II HLA-epitope restrictionsHLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responsesOseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesChemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceConserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentUniversal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusPreexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection.Characterization of pandemic influenza immune memory signature after vaccination or infection.Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenzaAssessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virusConservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell ResponsesMemory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.Cross-protective immunity to influenza A viruses.Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.Immunity to seasonal and pandemic influenza A virusesCD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.Molecular docking analysis of 2009-H1N1 and 2004-H5N1 influenza virus HLA-B*4405-restricted HA epitope candidates: implications for TCR cross-recognition and vaccine developmentConserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes.Epistatically interacting substitutions are enriched during adaptive protein evolution
P2860
Q21090975-DADCB9EE-B3C4-4BD4-AF91-7F307237C616Q21128791-11F5382A-02FB-47E9-BFE9-50696213DAE9Q26744622-4D97D180-91DD-4887-B415-14D4954ADA4FQ26772701-DB9077E5-5AFF-44BA-9300-7ED017707339Q26991896-D24DC0B7-7037-4BD7-9678-89BE40B6FD5AQ27013972-4EB6A6C4-A225-4165-AE39-D9C1EA68D266Q27348520-0B4011A8-7E0F-4F88-A0F2-DE650981A37CQ27489679-8C2212A8-CDEF-4320-9CF1-3E5C9BA778E9Q27663289-20CC1493-151B-4E30-B167-B2667499310FQ27673392-5F65D373-CA3A-4804-8282-8BD6965612D5Q27673689-329F1437-74E6-4761-A5A7-DAE2D6D47F7BQ27676834-BCD737E4-BD19-4DA9-9B19-26CEC94E0025Q28395866-1117E2AA-DC01-40E9-8199-02A82BF0F28EQ28473871-7BE53702-0296-4795-81A8-7278CB21B73EQ28548477-C0FBACFE-851D-42C1-85A0-ACD8F142B6E2Q28552025-A1CA8591-2ED5-4256-8AC8-8D8D9E48F217Q30226873-E5C91877-4A68-4E9B-A6C6-E4795BF4059AQ30352021-E78C0ACA-5E49-456F-AF79-A86EAB637904Q30355817-BE4609E6-C8A6-4C16-A443-36745E3B2D74Q30359962-8B6F2B51-7197-4C40-AB40-F6235B3815A5Q30362529-97D6E8BD-A1FE-4913-BA3C-7E87F43D6C68Q30363416-2795A4E6-598F-47EE-B257-D1C23442B1E6Q30375348-768050CF-4255-4204-B2FF-E12E98B25B86Q30375714-942BC405-97A8-47F8-8B4A-B815D7D00B89Q30376369-B4555033-FE7C-4D68-A76F-B389366FF969Q30379213-88B0BAC8-3995-4F93-8A18-863167B6CE04Q30384376-85CA2F70-A804-4794-B3D4-745ED018D1D1Q30384675-F67E8DDB-A727-4198-9E3E-6555A5AFCBBEQ30386346-F4587F49-3E46-409B-8E10-E801AD3651F1Q30388401-033571D8-F8D6-4576-B756-9DEDF6395916Q30388522-FAF1C583-BF59-4100-9E6F-C47DD6A9A6D4Q30390932-33481F1C-FA10-4BD7-B187-B1EDF3F41FBEQ30396399-27BE515A-6D51-4054-8252-A5A391ACA3B0Q30397362-D85A50E9-F4C4-4BF8-BAB6-EBA347FBCE8DQ30399357-82A28A63-9628-4F53-9467-B512B70C4F55Q30423542-22BD9D7E-88FB-4861-B22C-ED940A6D02E4Q30426623-A81A07FF-9658-46F9-BEA1-1CF92307C36AQ30430651-928D2A2C-8663-4934-9DEE-195309EC5C91Q33490243-047BDD89-8534-47E8-9B95-CC9658F35633Q33583647-B4514F70-23DC-4B6B-9701-6EEA307B440B
P2860
Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunomic analysis of the repe ...... or influenza A virus in humans
@en
type
label
Immunomic analysis of the repe ...... or influenza A virus in humans
@en
prefLabel
Immunomic analysis of the repe ...... or influenza A virus in humans
@en
P2093
P2860
P356
P1433
P1476
Immunomic analysis of the repe ...... or influenza A virus in humans
@en
P2093
Carla Oseroff
Erika Assarsson
Howard Grey
Huynh-Hoa Bui
Innocent N Mbawuike
Jean Glenn
Jeff Alexander
John Sidney
Mark J Newman
Qing Zhang
P2860
P304
12241-12251
P356
10.1128/JVI.01563-08
P407
P577
2008-10-08T00:00:00Z